Filter
745
Filtered Results: 745
Text search:
World
Health
Organization
WHO,
Regional
Office
for
the
Eastern
Mediterranen
Featured
Recommendations
104
New Publications
151
Language
Document type
No document type
262
Studies & Reports
197
Guidelines
129
Manuals
62
Strategic & Response Plan
38
Training Material
15
Fact sheets
13
Situation Updates
12
Infographics
7
Resource Platforms
6
Brochures
1
App
1
Online Courses
1
Videos
1
Countries / Regions
Global
68
Syria
24
Africa
21
Middle East and North Africa
19
Western and Central Europe
16
Yemen
10
Somalia
9
South–East Asia Region
8
Sudan
7
Latin America and the Carribbean
7
Pakistan
6
West and Central Africa
6
Eastern Europe
6
Nigeria
5
Ethiopia
5
Sierra Leone
4
Liberia
4
Iraq
4
Jordan
4
Afghanistan
4
Lebanon
4
Myanmar / Burma
4
East and Southern Africa
4
Eastern Europe and Central Asia
4
Saudi Arabia
3
Ghana
3
Uganda
3
India
3
Turkey
3
Kenya
3
Rwanda
3
Asia
3
Iran
3
Senegal
2
Philippines
2
Nepal
2
Thailand
2
China
2
South Africa
2
Bangladesh
2
North Macedonia
2
Ukraine
2
Libya
2
Western Pacific Region
2
Venezuela
2
Congo, Democratic Republic of
1
Morocco
1
USA
1
Cameroon
1
Egypt
1
Tanzania
1
Cambodia
1
Benin
1
Croatia
1
Ecuador
1
Greece
1
Palestine
1
Albania
1
Djibouti
1
Russia
1
Qatar
1
Georgia
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
107
Countries
95
Public Health
82
Women & Child Health
67
Key Resources
39
Capacity Building
24
Pharmacy & Technologies
15
Toolboxes
Mental Health
88
COVID-19
82
Planetary Health
46
Rapid Response
45
TB
40
HIV
39
Caregiver
33
NTDs
32
Conflict
30
Refugee
29
AMR
29
Global Health Education
28
Disability
26
NCDs
24
Pharmacy
19
Ebola
11
Polio
10
Zika
7
Cholera
6
Natural Hazards
5
Specific Hazards
4
Health Financing Toolbox
4
Typhoon
1
Social Ethics
1
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection...
Outstanding child and adolescent TB priorities include the need to: find the missing children with active TB and link them to TB care; prevent TB in children ... are in contact with infectious TB cases (through implementation of active contact investigation and provision of preventive treatment); and advance integration within general child health services, including maternal and child health/ reproductive, maternal, newborn, child and adolescent health, HIV, nutrition and other programmes.
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, ... has developed a system of indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and performance of key national pharmaceutical structures and processes. Level II indicators measure key outcomes of these structures and processes in the areas of access, product quality and rational use. These indicators can be used to assess progress over time; to compare situations between countries; and to reassess and prioritize efforts based on the results.
This Fact Book gives the results of the assessment of Level I indicators conducted in 2003 and of Level II indicator surveys conducted between 2002 and 2004
The World Health Organization organized a Consultation of National Leprosy Programme managers, p...
The report reveals that good IPC programmes can reduce health care infections by 70 %. oday, out of every 100 patients in acute-care hospitals, seven patients in high-income countries and 15 patient...
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies o...
A manual for developing national action plans.This manual for developing national action plans to address antimicrobial resistance has been developed at t... request of the World Health Assembly to assist countries in the initial phase of developing new, or refining existing national action plans in line with the strategic objectives of the Global Action Plan. It proposes an incremental approach that countries can adapt to the specific needs, circumstances and available resources of each individual country. Details of actions to be taken will vary according to national contexts
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The gl...
The global emergence of antimicrobial resistance (AMR) is posing a threat to human health. Putting resources into the containment of AMR – includ...
This document provides guidance on how to implement contact screening and chemoprophylaxis with single-dose rifampicin. The contents are logically ordered: counselling and obtaining consent, identification and listing of index case, listing of conta...
This document seeks to help health communication professionals working on the topic of immunization more effectively communicate about Events Supposedly Attributed to Vaccination and Immunization (E...
A review of proactive risk assessment and risk management practices to ensure the safety of drinking-water
Based on information gathered from 118 countries representing every region of the glob...
Based on information gathered from 118 countries representing every region of the glob...
Out of the shadows
People affected by impairments and disabilities associated with TB are even more likely to belong to marginalized segments of society and are more likely to have their human rights unprotected. The challenges faced by people affected by TB include <... consequences of impairment and disability associated with the disease, its treatment as well as with the stigma and discrimination applied to people affected by TB. There is now compelling evidence that the disease and its treatment affect quality of life and life expectancy even after successful treatment.
The WHO Global Tuberculosis Programme has produced the first policy brief on TB-associated disability, building on the increasing evidence in recent years on the unaddressed needs of people with TB who experience impairment and disability while on TB treatment and after completing TB treatment.
Preliminary overview of refugees and migrants self-reported impact of COVID-19
The study surveyed over 30,000 refugees and migrants living in 170 countries. Many of the respondents had fled war or ...
at the national and acute health care facility level
The World Health Organization (WHO) and ... global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance...
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing ... threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i) improve the detection of resistance to ensure a timely response; ii) delay the emergence of resistance to artemisinin and artemisinin-based combination therapy (ACT) partner drugs; and iii) limit the selection and spread of resistant parasites where resistance has been confirmed.
WHO Team
Global Malaria Programme
Editors
World Health Organization
Number of pages
87
Reference numbers
ISBN: 978 92 4 006026 5
Copyright
Against this background of nearly 20 years of experience of research, development and
improvement in patient safety, the role of incident and adverse event reporting, as well as the
benefits that ...
